StHealth Private Equity Medtech Fund. Alternative Investment BDC.
StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with both yield...
Former Tesla Foundation Vice Chairman Joins StHealth BDC.
St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board of directors.
Dr....
Hercules BDC (HTGC) $13, to Present at FB Riley.
Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference
PALO ALTO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the...
Innovus (INNV) in Silicon Review Interview.
POISED FOR INNOVATION.
The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...
Innovus (INNV) Conference Call Transcript.
Q1 2019 Results, 5/15/19.
Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET
Company Participants
Bassam Damaj - President and CEO
Ryan...
Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)
(Originally published 4/25/2018)
“I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
Beyonce Tells Uber “Pay me in Stock!”
We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four years ago, Beyoncé...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...














